Get the Stockscreener App
3.65
1.88%
-0.07
After Hours:
3.59
-0.06
-1.64%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $3.65, with a volume of 23,175.
It is down -1.88% in the last 24 hours and down -3.05% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.72
Open:
$3.85
24h Volume:
23,175
Relative Volume:
0.09
Market Cap:
$3.83M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-7.9348
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-4.70%
1M Performance:
-3.05%
6M Performance:
-80.61%
1Y Performance:
-63.49%
1-Day Range:
$3.65
$3.85
1-Week Range:
$3.65
$4.10
52-Week Range:
$3.00
$82.50
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
3.65 | 1.72M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Published on: 2025-07-31 20:48:54 - Newser
Published on: 2025-07-31 20:33:24 - Newser
Backtesting results for Shuttle Pharmaceuticals Holdings Inc. trading strategiesEntry Confirmation Based on Volatility Analysis - Newser
Why Shuttle Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionChart Driven Opportunity Scanner with Alerts - Newser
What analysts say about Shuttle Pharmaceuticals Holdings Inc. stock outlookDeep Stock Performance and Volatility Analysis - Newser
Shuttle Pharmaceuticals COO Resigns Amid Leadership Changes - TipRanks
Will Shuttle Pharmaceuticals Holdings Inc. Benefit From Broader Market BounceBuy Alerts With Low Risk Confirmation Noted - metal.it
Published on: 2025-07-30 09:07:32 - metal.it
What makes Shuttle Pharmaceuticals Holdings Inc. stock price move sharplyFree Trade Ready Stock Watch for Short Term - Newser
How to use Fibonacci retracement on Shuttle Pharmaceuticals Holdings Inc.Free Early Entry Tips With Low Risk Zone - Newser
What recovery options are there for Shuttle Pharmaceuticals Holdings Inc.Forecasting Stock Moves with AI Insights - Newser
Published on: 2025-07-29 11:41:32 - metal.it
Published on: 2025-07-29 11:27:07 - metal.it
Published on: 2025-07-29 03:35:31 - Newser
Published on: 2025-07-29 02:08:45 - metal.it
Is Shuttle Pharmaceuticals Holdings Inc. a growth stock or a value stockPost Market Growth Plan To Watch Now - jammulinksnews.com
Published on: 2025-07-28 20:14:37 - metal.it
What are the latest earnings results for Shuttle Pharmaceuticals Holdings Inc.Maximize gains with data-driven stock picks - jammulinksnews.com
Should I hold or sell Shuttle Pharmaceuticals Holdings Inc. stock in 2025Free Market Volatility Navigation Tips - jammulinksnews.com
Published on: 2025-07-28 04:35:50 - Newser
What is Shuttle Pharmaceuticals Holdings Inc. company’s growth strategyBuild wealth steadily with proven stock picks - jammulinksnews.com
How strong is Shuttle Pharmaceuticals Holdings Inc. company’s balance sheetUnlock powerful market insights for success - jammulinksnews.com
Is Shuttle Pharmaceuticals Holdings Inc. stock overvalued or undervaluedIdentify safe investments with exceptional yields - jammulinksnews.com
Why is Shuttle Pharmaceuticals Holdings Inc. stock attracting strong analyst attentionAchieve rapid capital gains with smart investing - jammulinksnews.com
How does Shuttle Pharmaceuticals Holdings Inc. generate profit in a changing economyGet exclusive access to premium stock research - jammulinksnews.com
What catalysts could drive Shuttle Pharmaceuticals Holdings Inc. stock higher in 2025Stay ahead with daily market updates - jammulinksnews.com
How does Shuttle Pharmaceuticals Holdings Inc. compare to its industry peersCapitalize on emerging market sectors - jammulinksnews.com
Shuttle Pharmaceuticals Holdings Inc. Company Revenue and Profit Trends: A Deep DiveHigh Return Setup Scanner - metal.it
How many analysts rate Shuttle Pharmaceuticals Holdings Inc. as a “Buy”Stay ahead with daily market updates - jammulinksnews.com
Is Shuttle Pharmaceuticals Holdings Inc. Stock a Smart Buy in 2025 Investment Analysis InsideStable Growth Stock Picks - Newser
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations - MSN
Shuttle Pharmaceuticals Holdings Inc. Stock Analysis and ForecastHigh-impact investment strategies - PrintWeekIndia
What drives Shuttle Pharmaceuticals Holdings Inc. stock pricePowerful growth strategies - Autocar Professional
Is Shuttle Pharmaceuticals Holdings Inc. a good long term investmentBreakthrough financial growth - Autocar Professional
What analysts say about Shuttle Pharmaceuticals Holdings Inc. stockExceptional risk-adjusted gains - Autocar Professional
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):